Edition:
United States

Exactech Inc (EXAC.OQ)

EXAC.OQ on NASDAQ Stock Exchange Global Select Market

30.50USD
21 Jul 2017
Change (% chg)

$0.15 (+0.49%)
Prev Close
$30.35
Open
$30.55
Day's High
$30.75
Day's Low
$30.40
Volume
21,482
Avg. Vol
10,452
52-wk High
$31.90
52-wk Low
$22.20

Latest Key Developments (Source: Significant Developments)

Exactech reports Q1 earnings per share $0.32
Tuesday, 25 Apr 2017 04:04pm EDT 

April 25 (Reuters) - Exactech Inc -:Exactech Q1 revenue up 6% to $69.5 million on 21% extremities growth.Sees Q2 2017 earnings per share $0.32 to $0.34.Q1 earnings per share $0.32.Sees Q2 2017 revenue $66.5 million to $68.5 million.Sees FY 2017 revenue $266 million to $272 million.Q1 revenue $69.5 million versus $65.3 million.Exactech inc sees FY 2017 adjusted eps target is $1.26-$1.32.  Full Article

Exactech posts Q4 loss per share $0.82
Tuesday, 21 Feb 2017 07:29am EST 

Exactech Inc : Exactech 2016 revenue up 7 pct to $257.6 million, Q4'16 revenue increased 6 pct to $66.2 million . Sees Q1 2017 earnings per share $0.26 to $0.28 . Q4 loss per share $0.82 . Sees Q1 2017 revenue $66 million to $68 million . Sees FY 2017 revenue $264 million to $272 million . Q4 revenue rose 7 percent to $257.6 million . Sees FY 2016 adjusted earnings per share $1.18 excluding items . Exactech Inc - on an adjusted basis diluted EPS target is $0.30-$0.32 for Q1 of 2017 . Exactech Inc sees FY 2017 GAAP earnings per share $1.20-$1.28 .Exactech Inc - during Q1 of 2017, co is anticipating an additional $0.9 million in charges related to divestiture of spine assets.  Full Article

Exactech reports divestiture of spine assets and restructuring charges
Tuesday, 31 Jan 2017 04:01pm EST 

Exactech Inc : Exactech announces divestiture of spine assets and restructuring charges . Exactech Inc - terms of transaction were not released . Exactech Inc says expects 2017 revenue to be in range of $264 - $272 million . Exactech - restructuring will result in a pre-tax charge to 2016 earnings in range of $15-17 million . Exactech says restructuring of its spine and biologics business segment including divestiture of its spine products business . Sees FY 2017 earnings per share $1.24 to $1.32 .Fy2017 earnings per share view $1.32, revenue view $271.1 million -- Thomson Reuters I/B/E/S.  Full Article

Exactech Q2 earnings per share $0.31
Monday, 1 Aug 2016 04:05pm EDT 

Exactech Inc : Exactech Q2 revenue up 8% to $66.1 million; net income up 20% to $4.4 million; diluted EPS $0.31 versus. $0.26 . Q2 earnings per share $0.31 . Q2 revenue $66.1 million versus I/B/E/S view $64.2 million . Sees FY 2016 revenue $253 million to $258 million . Q2 earnings per share view $0.30 -- Thomson Reuters I/B/E/S . Sees Q3 2016 earnings per share $0.21 to $0.23 . Sees Q3 2016 revenue $58 million to $60 million . Q3 earnings per share view $0.24, revenue view $58.8 million -- Thomson Reuters I/B/E/S .Fy 2016 earnings per share view $1.17, revenue view $254.5 million -- Thomson Reuters I/B/E/S.  Full Article

Exactech Inc gives Q2 2016 revenue guidance; increases FY 2016 revenue guidance
Tuesday, 26 Apr 2016 04:05pm EDT 

Exactech Inc:Looking forward, Exactech increased FY 2016 revenue guidance to $250-$257 million and its diluted EPS target to $1.14 - $1.19.For the Q2 2016, the company anticipates revenues of $63-$65 and diluted EPS of $0.29-$0.31.  Full Article

Exactech acquires Australian distributor
Monday, 1 Feb 2016 04:11pm EST 

Exactech Inc:Says the acquisition of its independent distribution partner, Exactech Australia Pty Ltd, effective Feb 1, 2016.Terms of the purchase were not disclosed.  Full Article

Exactech Inc announces sale of Dental Biologic assets to Salvin Dental Specialties
Monday, 4 Jan 2016 10:00am EST 

Exactech Inc:Announces sale of Dental Biologic assets to Salvin Dental Specialties.Financial terms were not disclosed.  Full Article

Exactech Announces Stock Repurchase Authorization
Monday, 7 Dec 2015 04:43pm EST 

Exactech, Inc:Says that its board of directors has authorized the company to buy back up to 1.0 million shares of Exactech stock over the next two years.  Full Article

Exactech Inc gives Q4 2015 guidance below analysts' estimates; reaffirms FY 2015 revenue guidance; raises low end of prior FY 2015 EPS guidance
Tuesday, 27 Oct 2015 04:05pm EDT 

Exactech Inc:Confirmed its updated FY 2015 revenue guidance to $239-$241 million and updated its diluted EPS target to $1.02--$1.04.Says revenue guidance for Q4 2015 is for revenues of $60-$62 million and a diluted EPS target of $0.27-$0.29.Q4 2015 revenue of $65 million and EPS of $0.35 - Thomson Reuters I/B/E/S.FY 2015 revenue of $256 million and EPS of $1.14 - Thomson Reuters I/B/E/S.  Full Article

Exactech Inc lowers FY 2015 guidance; gives Q4 2015 guidance below analysts' estimates
Thursday, 15 Oct 2015 04:05pm EDT 

Exactech Inc:Expects revenues for Q4 2015 to be approximately $56 million and diluted earnings per share for the quarter to be in the range of $0.18 - $0.20.Expects revenue for FY 2015 to be in the range of $239 million to $241 million and EPS in the range of $1.00 to $1.04.Q4 2015.Q4 2015 revenue of $66 million and EPS of $0.38 - Thomson Reuters I/B/E/S.FY 2015 revenue of $248 million and EPS of $1.18 - Thomson Reuters I/B/E/S.  Full Article

BRIEF-Exactech announces successful first surgeries with new preserve stem and shoulder application

* Exactech announces successful first surgeries with new equinoxe® preserve stem and exactechgps® shoulder application